You are here: Industry Insights > NHS

News List

Project Hercules to lead way in Duchenne muscular dystrophy europeanpharmaceuticalreview
April 30, 2019
Pharmaceutical companies are sponsoring a project to generate, align and share disease-level data across an entire condition for health technology assessments…
Experts ‘deeply concerned’ about NHS’ long-term sustainability fiercepharma
April 28, 2019
New data from the Office of National Statistics shows that between 1997 and 2017, total healthcare expenditure in the UK increased from £54.5 billion to £177.4 billion, growing by an average annual rate of 6.1%.
NHS set to fund brain surgery for deaf children pharmatimes
April 24, 2019
NHS England has announced plans to fund pioneering new brain surgery for children who are deaf. The surgery will enable them to experience the sensation of hearing for the first time, and will be made routinely available.
NHS to roll out mental health job coaches, helping thousands pharmatimes
April 24, 2019
NHS England has announced a major expansion of its Individual Placement and Support (IPS) scheme, designed initially to help tens of thousands of patients with serious mental health problems who want to employment.
Cell therapy rejected for aggressive adult lymphoma on the NHS europeanpharmaceuticalreview
April 18, 2019
A CAR-T immunotherapy for adults with an aggressive form of non-Hodgkin lymphoma has been provisionally rejected by the NHS…
Brexit will have ‘minimal’ effect on R&D, expert says europeanpharmaceuticalreview
April 12, 2019
Jonathan Sheffield, OBE, was presenting at the PING (Pharmaceutical Industry Network Group) Brexit Conference 2019 in Hertfordshire, UK…
'Routemap' designed to help innovators navigate 'maze' to NHS pharmatimes
April 11, 2019
The AHSN Network and the Association of British HealthTech Industries (ABHI) have launched a report of the MedTech – or medical technology - landscape, aimed at accelerating the entry...
NICE recommends BMS’ Opdivo-Yervoy combination for RCC pharmaceutical-technology
April 09, 2019
Bristol-Myers Squibb (BMS) has announced that the National Institute of Health and Care Excellence (NICE) has recommends Opdivo (nivolumab) and...
NHS to double diabetes prevention programme after patients lose 60,000kg collectively pharmatimes
April 04, 2019
NHS England has announced that patients who have completed its NHS type II diabetes prevention programme (DPP) have lost almost 60,000kg between them.
Number of prescription rises but cost falls again pharmatimes
April 02, 2019
Latest data from NHS Digital shows an increase in the number of prescription items dispensed in the community, but a drop in their cost to the NHS.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page